Tema Oncology ETF
CANC
6 hedge funds and large institutions have $3.87M invested in Tema Oncology ETF in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
21.74% less ownership
Funds ownership: 26.85% → 5.11% (-22%)
71% less capital invested
Capital invested by funds: $13.2M → $3.87M (-$9.29M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$222K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$9.31K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.61K |
| 4 |
PS
Principal Securities
Des Moines,
Iowa
|
+$1.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$9.85M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$49 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
| $3.64M | -$9.85M | -391,643 | -76% |
|
|
2
Jane Street
New York
| $213K | +$222K | +8,829 | New |
|
|
3
Osaic Holdings
Scottsdale,
Arizona
| $8.91K | +$9.31K | +370 | New |
|
|
HI
4
Harbour Investments
Madison,
Wisconsin
| $7.61K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $5.37K | +$5.61K | +223 | New |
|
|
PS
6
Principal Securities
Des Moines,
Iowa
| $1.22K | +$1.26K | +50 | New |
|
|
7
Fidelity Investments
Boston,
Massachusetts
| – | -$49 | -2 | Closed |
|
CANC Hedge Fund Activity: Q1 2025 in Review
6 of the 7,465 institutional investors tracked by Wall St. Rank reported a position in Tema Oncology ETF (CANC) for Q1 2025, worth a combined $3.87M — down 71% from $13.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CANC positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $222K. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $9.85M.
- 6 institutional investors held Tema Oncology ETF (CANC) as of Q1 2025, up from 3 in Q4 2024.
- Funds reported $3.87M of Tema Oncology ETF stock for Q1 2025, down 71% quarter-over-quarter.
- 4 funds opened new Tema Oncology ETF positions in Q1 2025 and 1 closed out, a net change of +3 holders.
- The largest Tema Oncology ETF buyer in Q1 2025 was Jane Street, an estimated $222K added.
- The largest Tema Oncology ETF seller in Q1 2025 was Thrivent Financial for Lutherans, an estimated $9.85M sold.
Based on aggregated 13F filings for Q1 2025.